p-Bromophenacyl bromide prevents cumene hydroperoxide-induced mitochondrial permeability transition by inhibiting pyridine nucleotide oxidation.
Mitochondrial permeability transition is commonly characterized as a Ca2+ -dependent non-specific increase in inner membrane permeability that results in swelling of mitochondria and their de-energization. In the present study, the effect of different inhibitors of phospholipase A2--p-bromophenacyl bromide, dibucaine, and aristolochic acid--on hydroperoxide-induced permeability transitions in rat liver mitochondria was tested. p-Bromophenacyl bromide completely prevented the hydroperoxide-induced mitochondrial permeability transition while the effects of dibucaine or aristolochic acid were negligible. Organic hydroperoxides added to mitochondria undergo reduction to corresponding alcohols by mitochondrial glutathione peroxidase. This reduction occurs at the expense of GSH which, in turn, can be reduced by glutathione reductase via oxidation of mitochondrial pyridine nucleotides. The latter is considered a prerequisite step for mitochondrial permeability transition. Among all the inhibitors tested, only p-bromophenacyl bromide completely prevented hydroperoxide-induced oxidation of mitochondrial pyridine nucleotides. Interestingly, p-bromophenacyl bromide had no affect on mitochondrial glutathione peroxidase, but reacted with mitochondrial glutathione that prevented pyridine nucleotides from being oxidized. Our data suggest that p-bromophenacyl bromide prevents hydroperoxide-induced deterioration of mitochondria via interaction with glutathione rather than through inhibition of phospholipase A2.
Zhukova
A
A
Institute of Theoretical and Experimental Biophysics, Pushchino, Russia.
Gogvadze
G
G
Gogvadze
V
V
D000098:Acetophenones / Q000494:pharmacology*; D000438:Alcohols / Q000378:metabolism; D000818:Animals; D034341:Aristolochic Acids / Q000494:pharmacology; D001555:Benzene Derivatives / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism; D003992:Dibucaine / Q000494:pharmacology; D005978:Glutathione / Q000378:metabolism; D005979:Glutathione Peroxidase / Q000378:metabolism; D005980:Glutathione Reductase / Q000378:metabolism; D006861:Hydrogen Peroxide / Q000378:metabolism; D008930:Mitochondria, Liver / Q000187:drug effects* / Q000378:metabolism; D010084:Oxidation-Reduction; D010539:Permeability / Q000187:drug effects; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D054467:Phospholipases A2; D011725:Pyridines / Q000378:metabolism*; D051381:Rats
D000098:Acetophenones; D000438:Alcohols; D034341:Aristolochic Acids; D001555:Benzene Derivatives; D011725:Pyridines; C000228:aristolochic acid I; D006861:Hydrogen Peroxide; D005979:Glutathione Peroxidase; D005980:Glutathione Reductase; D010741:Phospholipases A; D054467:Phospholipases A2; D005978:Glutathione; D003992:Dibucaine; C007164:cumene hydroperoxide; C006821:4-bromophenacyl bromide; D002118:Calcium